Primary and secondary objectives
SECONDARY
This was a randomized, double-blind, placebo-controlled, first-in-human study in healthy adults. The primary objective was to assess the safety and tolerability of single and multiple doses of GB1211. The secondary objectives were to evaluate the PK of single and multiple doses of GB1211 in participants’ plasma and urine (single dose PK only were evaluated in the urine), and to determine the effect of food intake on the single dose PK.